Posts
- Category: hdbuzz (continued)
- Category: home
- Data expand potential indications both within schizophrenia and to other neuropsychiatric disorders
- A Monoclonal Antibody TrkB Receptor Agonist as a Potential Therapeutic for Huntington’s Disease
- Can a virtual brain replace lab rats?
- Could a 'brain shuttle' get Huntington's disease drugs to where they're needed?
- Exon Skipping Prevents Formation of Toxic Protein Fragments in Huntington's Disease
- FDA Grants Fast Track Designation to Omeros' OMS824 Huntington's Disease Program
- Game-changers in the fight against disease: a report from the World Stem Cell Summit
- Joint HDBuzz Prizewinner: Pennies for your neurons — copper’s bad influence on Huntington’s disease
- L’UNITÀ OPERATIVA COMPLESSA PER LA CONTINUITÀ ASSISTENZIALE E LA MALATTIA DI HUNTINGTON
- MEDICO E PAZIENTE CON MH: IL COMPLESSO RAPPORTO CON LA VERITÀ
- Meet the Rare Disease Day Ambassador 2014: Sean Hepburn Ferrer
- NEWSHD.NET un'anno insieme
- Nutritional supplement slows Huntington’s
- Omeros Announces Enrollment in Second Phase 2 Clinical Trial with OMS824
- Prana announces results of Reach2HD trial of PBT2 for Huntington's disease
- Prana Announces Successful Phase 2 Results in Huntington Disease Trial
- Prana Biotechnology Investor Presentation and Audio Recording - Phase 2 HD trial
- Preventing Formation of Toxic N-Terminal Huntingtin Fragments Through Antisense Oligonucleotide-Mediated Protein Modification
- Raptor Announces Clinical Results With RP103 in Huntington's Disease Phase 2/3 Trial
- Researchers discover how to target and disable ‘bad apple’ proteins
- Scientists identify new Huntington disease pathway
- Stem cells could help in the battle against major brain diseases – scientists reveal latest research
- TERAPIE CHE RIDUCONO LA QUANTITÀ DI HUNTINGTINA ANOMALA PRODOTTA: COSA BOLLE IN PENTOLA.
- Treatments For Neurodegenerative Disorders - Global Forecast, Market Share, Size, Growth And Industry Analysis, 2012 - 2018
- Category: important
- 2015 HD Therapeutics Conference
- 2CARE study of coenzyme Q for Huntington's disease ends in disappointment
- 8th Plenary Meeting EHDN 2014 Barcelona: 19-21 settembre 2014 - Report
- 9th June, 2016 - Professor Sarah Tabrizi, Director of UCL’s Huntington’s Disease Centre, gives keynote speech at Google’s Zeitgeist event
- A breakdown product of aspirin blocks cell death associated with Alzheimer's, Parkinson's and Huntington's diseases
- A Field Guide to Working with Mouse Models of Huntington’s Disease
- A Gene Linked to Disease Found to Play a Critical Role in Normal Memory Development
- A newly discovered way for cells to die
- A recycled drug gives us new insight in to HD
- A starring role for astrocytes in Huntington's disease?
- Activity of Huntington's disease gene curbed for six months in mice
- Advances on many fronts in the battle against the protein that causes Huntington's disease
- Affrontare il rischio genetico e proteggere la speranza
- Amendment to the RG6042 Phase III GENERATION HD1 study design
- Animal study points to a treatment for Huntington's disease
- Annunciato trial clinico per la Malattia di Huntington: farmaco per l' abbassamento dei livelli di huntintina entra in Fase I di sperimentazione nel 2015
- Auspex Announces Positive Topline Results From Registration Trial of SD-809 for Chorea Associated With Huntington's Disease
- Auspex Pharmaceuticals Receives FDA Orphan Drug Designation of SD-809 for Treatment of Huntington's Disease
- BARCELLONA 19 - 21 SETTEMBRE: 8° MEETING PLENARIO DEL NETWORK EUROPEO PER LA MALATTIA DI HUNTINGTON – NOVITA’ E PROSPETTIVE
- Brain Degeneration In Huntington’s Disease Caused By Amino Acid Deficiency
- BRAIN Unit researchers break Huntington’s disease stigma
- Broken signals lead to neurodegeneration
Plugin by dagondesign.com
